Sanara MedTech Inc. (SMTI) Stock Forecast
SMTI analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.00 / 5 from 3 analysts
- Price target
- $35.00 average of analyst targets
- Upside to target
- +5.5% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $0.06
- 52-week range
- $16.34 – $35.28
SMTI analyst ratings
3 analystsNumber of analysts at each rating.
SMTI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SMTI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.02 | $0.02 | $0.02 | — | — | 1 |
| Current fiscal year (2026) | $0.20 | $0.20 | $0.20 | −$4.36 | +103.7% | 1 |
| Next fiscal year (2027) | $0.54 | $0.54 | $0.54 | $0.20 | +170.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SMTI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $29.5M | $29.5M | $29.5M | +12.0% | 1 |
| Current fiscal year (2026) | $116.6M | $116.6M | $116.6M | +13.1% | 1 |
| Next fiscal year (2027) | $133.2M | $132.0M | $134.4M | +14.2% | 2 |
SMTI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SMTI revenue: reported and forecast
SMTI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0.0% | 0 up · 0 down |
| Current fiscal year (2026) | $0.18 | $0.18 | $0.18 | $0.18 | $0.20 | +11.1% | 1 up · 0 down |
| Next fiscal year (2027) | $0.54 | $0.54 | $0.54 | $0.54 | $0.54 | 0.0% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SMTI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SMTI beat in 5 of 12.
What analysts expect from SMTI
3 analysts cover Sanara MedTech; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $35.00, 5.5% above the latest close of $33.16. Analysts expect earnings of $0.20 per share for 2026, +103.7% from a year earlier. For 2027 the average estimate is $0.54 per share on revenue of $133.2 million. Sanara MedTech beat the EPS estimate in 5 of the last 12 quarters.
Related: SMTI income statement, SMTI key metrics, SMTI chart. See the SMTI stock overview for the latest quote and news.
SMTI forecast FAQ
What is Sanara MedTech's price target?
The average analyst price target for Sanara MedTech is $35.00, 5.5% above the latest close of $33.16.
Is Sanara MedTech a buy, hold or sell?
Of 3 analysts covering Sanara MedTech, 0 rate it a strong buy, 0 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Sanara MedTech's EPS forecast?
Analysts forecast $0.20 per share for 2026 (range $0.20 to $0.20); for 2027 the estimate is $0.54.
What is Sanara MedTech's revenue forecast?
The average revenue estimate for 2026 is $116.6 million, growth of 13.1%; for 2027 it is $133.2 million.
When does Sanara MedTech report earnings?
Sanara MedTech is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $0.06.
Does Sanara MedTech usually beat earnings estimates?
Sanara MedTech reported EPS at or above the analyst estimate in 5 of the last 12 quarters.